On September 22, 2023, Michael C. Barnes, Counsel to Aimed Alliance, participated in a panel discussion on health policy at…
On July 27, 2023, a bipartisan group of lawmakers issued a Request for Information (RFI) regarding the regulation of hemp-derived…
In the realm of digital therapeutics, the health care landscape is poised for potential transformation as the Centers for Medicare…
The rising popularity of cannabidiol (CBD) has ignited conversations about its potential benefits, but SAMHSA’s advisory fact sheet sheds light…
On Aug. 16, Aimed Alliance published two new resources addressing critical aspects of cannabidiol (CBD) regulation. The Food and Drug…
On July 27, 2023, a bipartisan group of lawmakers issued a Request for Information (RFI) regarding the regulation of hemp-derived…
Most primary care providers (PCPs) are hesitant to recommend cannabidiol (CBD) products to patients given doubts regarding the products’ safety…
The office of the Attorney General recently announced a crackdown on unregulated THC products, like delta-8. Earlier this year, the…
On March 17, 2023, the Commonwealth Court of Pennsylvania held, in Fegley v. Firestone Tire & Rubber (Workers’ Comp. Appeal…
On February 13, 2023, the Drug Enforcement Administration (DEA) responded to an inquiry by a North Carolina attorney regarding the…